Vascular risk factors and mild cognitive impairment in the elderly population in southwest China

American Journal of Alzheimer's Disease and other Dementias

Volumn 29, Issue 3, 2014, Pages 242-247

  Zou, Yan ^a,b   Zhu, Qinlan ^a   Deng, Yongtao ^a   Duan, Jingxi ^a   Pan, Ling ^a   Tu, Qi ^a   Dai, Rong ^a   Zhang, Xuemei ^c   Chu, Leung Wing ^d   Lü, Yang ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b AFFILIATED HOSPITAL OF NORTH SICHUAN MEDICAL COLLEGE   (China)

^c THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

cerebrovascular disease; coronary heart disease; dyslipidemia; hypertension; mild cognitive impairment; vascular risk factors

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CHINA; CHOLESTEROL BLOOD LEVEL; CLINICAL DEMENTIA RATING; COGNITION; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; FEMALE; GERIATRIC DISORDER; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; POPULATION RESEARCH; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; VERY ELDERLY; EPIDEMIOLOGY; MIDDLE AGED; RISK FACTOR; VASCULAR DISEASES;

AGED; AGED, 80 AND OVER; CHINA; HUMANS; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; RISK FACTORS; VASCULAR DISEASES;

EID: 84900400996     PISSN: 15333175     EISSN: 19382731     Source Type: Journal    
DOI: 10.1177/1533317513517042     Document Type: Article

References (53)

1. Manly JJ, Tang M, Schupf N, Stern Y, Vonsattel JP, Mayeux R. Frequency and course of mild cognitive impairment in a multiethnic community. Ann Neurol. 2008 ; 63 (4). 494-506
2. Plassman BL, Langa KM, Fisher GG, et al. Prevalence of cognitive impairment without dementia in the United States. Ann Intern Med. 2008 ; 148 (6). 427-434
3. Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E. Alzheimer's disease. Lancet. 2011 ; 377 (9770). 1019-1031
4. Austin BP, Nair VA, Meier TB, et al. Effects of hypoperfusion in Alzheimer's disease. J Alzheimers Dis. 2011 ; 26 (suppl 3). 123-133
5. Okamoto Y, Yamamoto T, Kalaria RN, et al. Cerebral hypoperfusion accelerates cerebral amyloid angiopathy and promotes cortical microinfarcts. Acta Neuropathol. 2012 ; 123 (3). 381-394
6. Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/American stroke association. Stroke. 2011 ; 42 (9). 2672-2713
7. Power MC, Weuve J, Gagne JJ, McQueen MB, Viswanathan A, Blacker D. The association between blood pressure and incident Alzheimer disease: a systematic review and meta-analysis. Epidemiology. 2011 ; 22 (5). 646-659
8. Roberts RO, Knopman DS, Geda YE, Cha RH, Roger VL, Petersen RC. Coronary heart disease is associated with non-amnestic mild cognitive impairment. Neurobiol Aging. 2010 ; 31 (11). 1894-1902
9. Pimentel-Coelho PM, Rivest S. The early contribution of cerebrovascular factors to the pathogenesis of Alzheimer's disease. Eur J Neurosci. 2012 ; 35 (12). 1917-1937
10. Deschaintre Y, Richard F, Leys D, Pasquier F. Treatment of vascular risk factors is associated with slower decline in Alzheimer disease. Neurology. 2009 ; 73 (9). 674-680
11. Fromm A, Lundervold AJ, Moen G, Skulstad S, Thomassen L. A vascular approach to mild amnestic cognitive impairment: a pliot study. Acta Neurol Scand. 2013 ; 127 (suppl 196). 73-76
12. Devine ME, Fonseca JA, Walker Z. Do cerebral white matter lesions influence the rate of progression from mild cognitive impairment to dementia?. Int Psychogeriatr. 2013 ; 25 (1). 120-127
13. Wysocki M, Luo X, Schmeidler J, et al. Hypertension is associated with cognitive decline in elderly people at high risk for dementia. Am J Geriatr Psychiatry. 2012 ; 20 (2). 179-187
14. Yasar S, Ko JY, Nothelle S, Mielke MM, Carlson MC. Evaluation of the effect of systolic blood pressure and pulse pressure on cognitive function: the Women's Health and Aging Study II. PLoS One. 2011 ; 6 (12). e27976
15. Tsivgoulis G, Alexandrov AV, Wadley VG, et al. Association of higher diastolic blood pressure levels with cognitive impairment. Neurology. 2009 ; 73 (8). 589-595
16. Qiu C, Winblad B, Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol. 2005 ; 4 (8). 487-499
17. Sierra C, Doménech M, Camafort M, Coca A. Hypertension and mild cognitive impairment. Curr Hypertens Rep. 2012 ; 14 (6). 548-555
18. Hebert LE, Scherr PA, Bennett DA, et al. Blood pressure and late-life cognitive function change: a biracial longitudinal population study. Neurology. 2004 ; 62 (11). 2021-2024
19. Li G, Rhew IC, Shofer JB, et al. Age-varying association between blood pressure and risk of dementia in those aged 65 and older: a community-based prospective cohort study. J Am Geriatr Soc. 2007 ; 55 (8). 1161-1167
20. Novak V, Hajjar I. The relationship between blood pressure and cognitive function. Nat Rev Cardiol. 2010 ; 7 (12). 686-698
21. Kerola T, Kettunen R, Nieminen T. The complex interplay of cardiovascular system and cognition: how to predict dementia in the elderly?. Int J Cardiol. 2011 ; 150 (2). 123-129
22. Carnevale D, Mascio G, D'Andrea I, et al. Hypertension induces brain amyloid accumulation, cognitive impairment, and memory deterioration through activation of receptor for advanced glycation end products in brain vasculature. Hypertension. 2012 ; 60 (1). 188-197
23. Grassi D, Ferri L, Cheli P, Di Giosia P, Ferri C. Cognitive decline as a consequence of essential hypertension. Curr Pharm Des. 2011 ; 17 (28). 3032-3038
24. Sharp SI, Aarsland D, Day S, Sønnesyn H. Ballard C. Hypertension is a potential risk factor for vascular dementia: systematic review. Int J Geriatr Psychiatry. 2011 ; 26 (7). 661-669
25. Stewart R, Xue QL, Masaki K, et al. Change in blood pressure and incident dementia: a 32-year prospective study. Hypertension. 2009 ; 54 (2). 233-240
26. Zheng L, Mack WJ, Chui HC, et al. Coronary artery disease is associated with cognitive decline independent of changes on magnetic resonance imaging in cognitively normal elderly adults. J Am Geriatr Soc. 2012 ; 60 (3). 499-504
27. Bajenaru O, Antochi F, Tiu C. Particular aspects in patients with coronary heart disease and vascular cognitive impairment. J Neurol Sci. 2010 ; 299 (1-2). 49-50
28. Selnes OA, Grega MA, Bailey MM, et al. Do management strategies for coronary artery disease influence 6-year cognitive outcomes?. Ann Thorac Surg. 2009 ; 88 (2). 445-454
29. Singh-Manoux A, Sabia S, Lajnef M, et al. History of coronary heart disease and cognitive performance in midlife: the Whitehall II study. Eur Heart J. 2008 ; 29 (17). 2100-2107
30. Bursi F, Rocca WA, Killian JM, et al. Heart disease and dementia: a population-based study. Am J Epidemiol. 2006 ; 163 (2). 135-141
31. Arntzen KA, Schirmer H, Wilsgaard T, Mathiesen EB. Impact of cardiovascular risk factors on cognitive function: the Tromsø study. Eur J Neurol. 2011 ; 18 (5). 737-743
32. Ganguli M, Fu B, Snitz BE, Hughes TF, Chang CC. Mild cognitive impairment: incidence and vascular risk factors in a population-based cohort. Neurology. 2013 ; 80 (23). 2112-2120
33. Eggermont LH, de Boer K, Muller M, Jaschke AC, Kamp O, Scherder EJ. Cardiac disease and cognitive impairment: a systematic review. Heart. 2012 ; 98 (18). 1334-1340
34. Jefferson AL, Himali JJ, Au R, et al. Relation of left ventricular rejection fraction to cognitive aging (from the Framingham Heart Study). Am J Cardiol. 2011 ; 108 (9). 1346-1351
35. Jefferson AL, Himali JJ, Beiser AS, et al. Cardiac index is associated with brain aging: the Framingham Heart Study. Circulation. 2010 ; 122 (7). 690-697
36. Appelman AP, van der Graaf Y, Vincke n KL, Mali WP, Geerlings MI. Combined effect of cerebral hypoperfusion and white matter lesions on executive functioning - The SMART-MR stud y. Dement Geriatr Cogn Disord. 2010 ; 29 (3). 240-247
37. Mazza M, Marano G, Traversi G, Bria P, Mazza S. Primary cerebral blood flow deficiency and Alzheimer's disease: shadows and lights. J Alzheimers Dis. 2011 ; 23 (3). 375-389
38. Pinkston JB, Alekseeva N, Gonzalez Toledo E. Stroke and dementia. Neurol Res. 2009 ; 31 (8). 824-831
39. Honjo K, Black SE, Verhoeff NP. Alzheimer's disease, cerebrovascular disease, and the amyloid cascade. Can J Neurol Sci. 2012 ; 39 (6). 712-728
40. Kliper E, Ben Bashat D, Bornstein NM, et al. Cognitive decline after stroke: relation to inflammatory biomarkers and hippocampal volume. Stroke. 2013 ; 44 (5). 1433-1435
41. Douiri A, Rudd AG, Wolfe CD. Prevalence of poststroke cognitive impairment South London stroke register 1995-2010. Stroke. 2013 ; 44 (1). 138-145
42. Jacquin A, Aboa-Eboulé C, Rouaud O, et al. Prior transient ischemic attack and dementia after subsequent ischemic stroke. Alzheimer Dis Assoc Disord. 2012 ; 26 (4). 307-313
43. Rist PM, Chalmers J, Arima H, et al. Baseline cognitive function, recurrent stroke, and risk of dementia in patients with stroke. Stroke. 2013 ; 44 (7). 1790-1795
44. Park SH, Kim JH, Choi KH, et al. Hypercholesterolemia accelerates amyloid induced cognitive deficits. Int J Mol Med. 2013 ; 31 (3). 577-582
45. Frisardi V, Solfrizzi V, Seripa D, et al. Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease. Ageing Res Rev. 2010 ; 9 (4). 399-417
46. Matsuzaki T, Sasaki K, Hata J, et al. Association of Alzheimer disease pathology with abnormal lipid metabolism: the Hisayama Study. Neurology. 2011 ; 77 (11). 1068-1075
47. Altman R, Rutledge JC. The vascular contribution to Alzheimer's disease. Clin Sci (Lond). 2010 ; 119 (10). 407-421
48. Koyama A, Stone K, Yaffe K. Serum oxidized low-density lipoprotein level and risk of cognitive impairment in older women. Neurobiol Aging. 2013 ; 34 (2). 634.e2-635.e2
49. Mielke MM, Zandi PP, Sjögren M, et al. High total cholesterol levels in late life associated with a reduced risk of dementia. Neurology. 2005 ; 64 (10). 1689-1695
50. West R, Beeri MS, Schmeidler J, et al. Better memory functioning associated with higher total and low-density lipoprotein cholesterol levels in very elderly subjects without the apolipoprotein e4 allele. Am J Geriatr Psychiatry. 2008 ; 16 (9). 781-785
51. Yin ZX, Shi XM, Kraus VB, et al. High normal plasma triglycerides are associated with preserved cognitive function in Chinese oldest-old. Age Ageing. 2012 ; 41 (5). 600-606
52. Anstey KJ, Lipnicki DM, Low LF. Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis. Am J Geriatr Psychiatry. 2008 ; 16 (5). 343-354
53. Zhuang L, Sachdev PS, Trollor JN, et al. Microstructural white matter changes, not hippocampal atrophy, detect early amnestic mild cognitive impairment. PLoS One. 2013 ; 8 (3). e58887